Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,322 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $287.74 | 16 | $0 (2021) |
| Daiichi Sankyo Inc. | $166.27 | 12 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $162.11 | 13 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $161.98 | 3 | $0 (2018) |
| PFIZER INC. | $69.28 | 5 | $0 (2023) |
| Flexion Therapeutics, Inc. | $64.17 | 3 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $51.45 | 3 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $47.81 | 3 | $0 (2022) |
| US WorldMeds, LLC | $35.19 | 3 | $0 (2018) |
| Nevro Corp. | $34.91 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.91 | 1 | Nevro Corp. ($34.91) |
| 2023 | $28.07 | 2 | DePuy Synthes Sales Inc. ($14.70) |
| 2022 | $47.81 | 3 | Biohaven Pharmaceutical Holding Company Ltd. ($47.81) |
| 2021 | $89.94 | 6 | Allergan, Inc. ($45.69) |
| 2020 | $139.10 | 10 | Allergan, Inc. ($90.08) |
| 2019 | $112.70 | 7 | Allergan Inc. ($34.29) |
| 2018 | $491.99 | 26 | AstraZeneca Pharmaceuticals LP ($161.98) |
| 2017 | $377.50 | 23 | Collegium Pharmaceutical, Inc. ($115.18) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Sports Early Intervention | ||||||
| 05/04/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: VACCINES | ||||||
| 09/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PRIMARY CARE | ||||||
| 08/17/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: PRIMARY CARE | ||||||
| 01/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: PRIMARY CARE | ||||||
| 10/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PRIMARY CARE | ||||||
| 07/29/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PRIMARY CARE | ||||||
| 05/25/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/18/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/15/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/19/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/17/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/10/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/16/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Musculoskeletal | ||||||
| 10/01/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/25/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/17/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/20/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/05/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2019 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: OSTEOARTHRITIS | ||||||
| 09/26/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/20/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 749 | 1,481 | $199,704 | $94,962 |
| 2022 | 9 | 755 | 1,446 | $181,889 | $80,434 |
| 2021 | 8 | 595 | 1,383 | $182,126 | $81,851 |
| 2020 | 8 | 518 | 1,241 | $161,204 | $72,936 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 251 | 893 | $113,411 | $55,136 | 48.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 120 | 124 | $29,636 | $12,721 | 42.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 130 | 136 | $17,272 | $8,555 | 49.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 113 | 155 | $11,625 | $6,050 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 64 | $7,168 | $4,033 | 56.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 36 | $6,408 | $2,473 | 38.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $4,602 | $1,776 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,672 | $1,333 | 49.9% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 17 | 17 | $3,213 | $1,246 | 38.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $2,497 | $1,028 | 41.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,200 | $610.26 | 50.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 213 | 678 | $86,106 | $37,937 | 44.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 123 | 130 | $31,070 | $13,801 | 44.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 169 | 341 | $25,575 | $10,395 | 40.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 111 | 115 | $14,605 | $6,487 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 77 | $8,624 | $4,727 | 54.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 25 | 38 | $6,764 | $2,799 | 41.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 15 | 15 | $3,405 | $1,577 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $3,340 | $1,383 | 41.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 32 | $2,400 | $1,327 | 55.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 213 | 911 | $115,697 | $51,696 | 44.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 103 | 111 | $26,529 | $11,945 | 45.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 108 | 117 | $14,859 | $6,592 | 44.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 82 | 127 | $9,525 | $3,861 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 60 | $6,720 | $3,857 | 57.4% |
About Dr. Christopher Luring, DO
Dr. Christopher Luring, DO is a Physical Medicine & Rehabilitation healthcare provider based in Novi, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2009. The National Provider Identifier (NPI) number assigned to this provider is 1740413954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Luring, DO has received a total of $1,322 in payments from pharmaceutical and medical device companies, with $34.91 received in 2024. These payments were reported across 78 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,322).
As a Medicare-enrolled provider, Luring has provided services to 2,617 Medicare beneficiaries, totaling 5,551 services with total Medicare billing of $330,183. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location Novi, MI
- Active Since 09/03/2009
- Last Updated 11/03/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1740413954
Products in Payments
- BOTOX (Biological) $170.06
- MOVANTIK (Drug) $161.98
- Xtampza ER (Drug) $128.09
- Movantik (Drug) $96.72
- NURTEC ODT (Drug) $79.81
- Morphabond ER (Drug) $69.55
- BOTOX CHRONIC MIGRAINE (Drug) $69.02
- Zilretta (Drug) $64.17
- LYRICA (Drug) $40.33
- Lucemyra/Lofexidine (Drug) $35.19
- Senza (Device) $34.91
- BOTOX - SPASTICITY (Drug) $34.23
- NUEDEXTA (Drug) $29.24
- EUFLEXXA (Device) $28.09
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $26.99
- HYSINGLA ER (Drug) $20.60
- Aimovig (Biological) $20.53
- XTAMPZA ER (Drug) $20.52
- XIFIXAN (Drug) $17.82
- RELISTOR ORAL (Drug) $17.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Novi
Dr. Eric Kovan, Do, DO
Physical Medicine & Rehabilitation — Payments: $12,057
Dr. Michael Haenick, Md, MD
Physical Medicine & Rehabilitation — Payments: $4,866
Dr. Jenny Michaels, Md Mph, MD MPH
Physical Medicine & Rehabilitation — Payments: $3,511
Dr. Dorin Deitch, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,477
Dennis Bandemer, Do, DO
Physical Medicine & Rehabilitation — Payments: $3,158
M Jackson, Md, MD
Physical Medicine & Rehabilitation — Payments: $2,217